1 year return (CAGR)
-
Aspire BioPharma, Inc. Exchange (NASDAQ, USD)
ASBP
8.33
+0.13 (+1.59%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
11.68M
Price/Sales
119.63
Ent value
1.30M
Price/Book
0.99
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.29 |
| Daily high | 8.83 |
| Daily low | 8.26 |
| Daily Volume | 31K |
| All-time high | 17.80 |
| 1y analyst estimate | - |
| Beta | 0.11 |
| EPS (TTM) | -10.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ASBP | S&P500 | |
| Current price drop from All-time high | -53.19% | -1.29% |
| Highest price drop | -98.95% | -56.47% |
| Date of highest drop | 6 May 2026 | 9 Mar 2009 |
| Avg drop from high | -68.31% | -10.68% |
| Avg time to new high | 63 days | 12 days |
| Max time to new high | 227 days | 1805 days |
News
